Stromal expression of CD10 in invasive breast carcinoma: A new predictor of clinical outcome
Iwaya K, Ogawa H, Izumi M et al. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. Virchows Arch 2002 440 : 589 93.
Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade
Makretsov NA, Hayes M, Carter BA et al. Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade. Mod Pathol 2007 20 : 84 9.
Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion
Bemis LT, Schedin P. Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Cancer Res 2000 60 : 3414 18.
CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: Implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors
Pan C, Cardarelli PM, Nieder MH et al. CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors. Cancer Res 2003 63 : 5526 31.